Should Invesco S&P SmallCap 600 Pure Value ETF (RZV) Be on Your Investing Radar? — Neutral
RZV Zacks Investment Research — July 17, 2025Looking for broad exposure to the Small Cap Value segment of the US equity market? You should consider the Invesco S&P SmallCap 600 Pure Value ETF (RZV), a passively managed exchange traded fund launched on 03/01/2006.
Capital Clean Energy Carriers Eyes LNG Market Leadership With High-Spec Fleet, Disciplined Chartering Strategy — Positive
CCEC Benzinga — July 17, 2025In a recent interview hosted by Webber Research & Advisory, Jerry Kalogiratos, CEO of Capital Clean Energy Carriers Corp. CCEC, provided a detailed overview of the company's strategic pivot to LNG shipping, its growth trajectory, and the broader market dynamics shaping the sector. The discussion, led by Michael Webber, Managing Partner at Webber Research and Advisory, explored long-term market fundamentals, fleet deployment strategy, capital structure, trading liquidity, and emerging trends such as the role of portfolio players and the rising importance of floating storage.
Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net Income — Negative
ALHC CI CNC CVS ELV MOH UNH Seeking Alpha — July 17, 2025A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecasts. Of the eight largest publicly traded US managed care insurers, all but two — UnitedHealth Group and Alignment Healthcare — are projected to report lower revenue compared with Q1 2025, while all eight are forecast to log higher revenue than Q2 2024. In Q2, all eight of the largest publicly traded US managed care insurers, except The Cigna Group, are expected to log lower net income sequentially, …
Talkspace is the largest in-network telehealth mental health provider in the US, benefiting from strong demand and a scalable, flexible clinician model. The strategic shift to a payor model has driven rapid revenue growth, improved profitability, and created a more attractive, affordable consumer offering. Financials are robust: 15%+ revenue growth, strong operating leverage, GAAP profitability, a fortress balance sheet, and active share buybacks support the investment case.
President Trump says Coca-Cola will use cane sugar in soda in United States — Positive
KO CNBC Television — July 17, 2025CNBC's Becky Quick reports on the latest news.
IDEXX Laboratories: A Business With Strong Fundamentals — Positive
IDXX Seeking Alpha — July 17, 2025I rate IDEXX Laboratories a buy, driven by a lasting surge in pet ownership and IDXX's leadership in veterinary diagnostics. New platforms like inVue Dx and Cancer Dx provide additional growth drivers, with strong early adoption and potential for margin expansion. IDXX's recurring revenue model, robust retention, and expanding high-margin consumables base support sustained revenue and earnings growth.
Velocity Clinical Research Partners with Palantir to Solve Clinical Trials' Payment Headache — Neutral
PLTR GlobeNewsWire — July 17, 2025DURHAM, N.C., July 17, 2025 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading fully integrated site organization, has announced a strategic partnership with Palantir Technologies (“Palantir”) to automate and streamline the notoriously complex payments reconciliation process in clinical trials.
Hyatt Hotels Corporation stock (NYSE: H) has experienced a robust performance lately, increasing by 10% over the last month, surpassing the broader S&P 500's 3% return and competitor Marriott International's (NASDAQ: MAR) 7% rise. However, after such a rally, the critical question is: what comes next?
Terex Announces Second Quarter 2025 Financial Results Conference Call — Neutral
TEX PRNewsWire — July 17, 2025NORWALK, Conn. , July 17, 2025 /PRNewswire/ -- Terex Corporation (NYSE: TEX) will host a conference call to review its second quarter 2025 financial results on Thursday, July 31, 2025 at 8:30 a.m.
Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline — Neutral
CLSD GlobeNewsWire — July 17, 2025- Proven In-Office, Repeatable, Non-Surgical Procedure for the Targeted Delivery of a Wide Variety of Therapies for Serious Retinal Diseases -
Ivanhoe Electric (IE) Stock Jumps 12.0%: Will It Continue to Soar? — Positive
IE Zacks Investment Research — July 17, 2025Ivanhoe Electric (IE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Roblox launches new age verification system to unlock unfiltered chats — Positive
RBLX CNBC — July 17, 2025Roblox is starting age-estimation technology for users who want to chat more freely on the social-gaming platform as part of its new "trusted connections" feature. Chief Safety Officer Matt Kaufman said the move coincides with "features that we really believe are something that should be limited to an older audience — 13 and over.
Identiv Sets Second Quarter 2025 Earnings Call for Thursday, August 7, 2025, at 5:00 PM EDT — Neutral
INVE PRNewsWire — July 17, 2025SANTA ANA, Calif. , July 17, 2025 /PRNewswire/ -- Identiv, Inc. (NASDAQ: INVE), a global leader in RFID- and BLE-enabled Internet of Things (IoT) solutions, will hold a teleconference and webcast on Thursday, August 7, 2025, at 5:00 PM EDT to discuss its financial results for the second quarter ended June 30, 2025.
Recurrent Energy Secures $260 Million Financing for Blue Moon Solar Project in Kentucky — Neutral
CSIQ PRNewsWire — July 17, 202594 MW Solar Facility Holds Power Purchase Agreement with Constellation KITCHENER, ON , July 17, 2025 /PRNewswire/ -- Recurrent Energy, a subsidiary of Canadian Solar Inc. ("Canadian Solar") (NASDAQ: CSIQ) and a global developer, owner, and operator of solar and energy storage assets, announced today it has closed project financing and tax equity for Blue Moon Solar. U.S. Bank, through its subsidiary U.S. Bancorp Impact Finance, is providing both tax equity and construction financing for the project, totaling $260 million.
NLS Pharmaceutics Highlights Continued Progress in iTOL-102 Diabetes Program as BIRD Foundation Approves Additional Milestone Payment to Kadimastem and iTolerance for Continued Co-Development of Type 1 Diabetes Cell Therapy — Neutral
NLSP PRNewsWire — July 17, 2025Approval Follows Successful Pre-IND Meeting with the U.S. FDA on iTOL-102, a Potential Cure for Type 1 diabetes that would circumvent the need for life-long immunosuppression drugs ZURICH , July 17, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP) ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system disorders, today announced that the Israel-U.S. Binational Industrial Research and Development Foundation (the "Bird Foundation") has approved another milestone-based funding payment to Kadimastem Ltd.
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results — Neutral
TECH PRNewsWire — July 17, 2025MINNEAPOLIS , July 17, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, August 6, 2025, at 8:00 a.m. CDT to review its fourth quarter and fiscal 2025 financial results.
I focus on wide-moat, growth-driven, financially robust companies trading below fair value, following Buffett's simplicity philosophy for long-term investing. Salesforce, ASML, and Equinix each lead their industries, benefit from strong secular trends, and offer sustainable dividend growth with low payout ratios. All three boast investment-grade credit ratings and robust balance sheets and are currently trading at attractive discounts to fair value estimates.
I-Mab Strengthens Givastomig Intellectual Property Portfolio through Acquisition of Bridge Health — Neutral
IMAB GlobeNewsWire — July 17, 2025ROCKVILLE, Md., July 17, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that it entered into a definitive agreement to acquire 100% ownership of Bridge Health Biotech Co., Ltd. (Bridge Health). The transaction provides I-Mab with the rights to bispecific and multi-specific applications (including bispecific and multi-specific antibodies and antibody drug conjugates (ADCs)), based on the Claudin 18.2 (CLDN18.2) parental antibody used in the Company's CLDN18.2 x 4-1BB bispecific antibody, givastomig.
Castle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company's Strong Culture — Neutral
CSTL GlobeNewsWire — July 17, 2025FRIENDSWOOD, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has earned multiple awards through the 2025 Top Workplaces program: a third consecutive national Healthcare Industry Top Workplaces award, with Castle ranking third among other recognized companies in its size bracket; a fourth consecutive regional Arizona Top Workplaces award from AZ Central; and consecutive national Top Workplaces Culture Excellence awards for Innovation, Work-Life Flexibility, Compensation & Benefits, Leadership and Purpose & Values. “Being recognized as a Top Workplace, year after year, demonstrates …